68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
Abroad (travel likely)RecruitingPHASE3
Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate · Prostate Cancer · BCR Prostate Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking University First Hospital, Beijing, China
Contact: Principal Investigator (Yan Fan)Xiangya Hospital Central South University, Changsha, China
Contact: Principal Investigator (Shuo Hu)Nanfang Hospital Southern Medical University, Guangzhou, China
Contact: Principal Investigator (Wanlong Tan)Fudan University Shanghai Cancer Center, Shanghai, China
Contact: Study coordinator (Principal Investigator) · info@telixpharma.com · 0086-021-64175590-88900Contact: Principal Investigator (Shaoli Song)West China Hospital of Sichuan University, Sichuan, China
Contact: Principal Investigator (Lin Li)Pengfei Shen (Sub-investigator)Wuhan Union Hospital, Wuhan, China
Contact: Principal Investigator (Xiaoli Lan, PhD)Zhongnan Hospital of Wuhan University, Wuhan, China
Contact: Principal Investigator (Yong He)Affiliated Hosptial of Jiangnan University, Wuxi, China
Contact: Principal Investigator (ChunJing Yu)